Abstract: Provided is a control rod motion monitoring method and a control rod motion monitoring system, in which a control rod insertion in an entire core is monitored at all time during operation of a reactor and, when an abnormality occurs, a signal is issued to a countermeasure device that automatically starts operation and an alarm is issued to prompt operation of an operator. An LPRM detector in an LPRM assembly of the entire core is divided into four channels for each height; indicated values are averaged at all time; the average indicated value is compared with a set point; and a signal is issued to a countermeasure device when an abnormality occurs.

Abstract: Provided is a control rod motion monitoring method and a control rod motion monitoring system, in which a control rod insertion in an entire core is monitored at all time during operation of a reactor and, when an abnormality occurs, a signal is issued to a countermeasure device that automatically starts operation and an alarm is issued to prompt operation of an operator. An LPRM detector in an LPRM assembly of the entire core is divided into four channels for each height; indicated values are averaged at all time; the average indicated value is compared with a set point; and a signal is issued to a countermeasure device when an abnormality occurs.

Abstract: The present invention provides an agent for improving mental disorders due to cerebral dysfunction and an agent for inhibiting vascular hyperpermeability each containing a hepatocyte growth factor. The agent for improving mental disorders according to the present invention is useful in improving mental disorders, particularly decline in learning and memory function, due to cerebral dysfunction occurred in blood circulation disorders in the brain (for example, cerebral infarction, cerebral hemorrhage, lacunar stroke, Biswanger's disease, cerebral thrombosis, subarachnoid hemorrhage, cerebrovascular moyamoya disease, carotid cerebral arterial fibrous muscular plasia, cerebral arterial sclerosis, internal carotid artery occlusion, hypertensive encephalopathy, cerebral edema, etc.) and neurodegenerative disorders (for example, multiple sclerosis, Parkinson's disease, Parkinson'syndrome, Huntington's chorea, cerebrovascular dementia and Alzheimer dementia), epilepsy, head injury, etc.